Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2012; 33(04): 221-223
DOI: 10.4103/0971-5851.107086
ORIGINAL ARTICLE

Etiologic and epidemiologic study of hepatocellular carcinoma in West Azarbaijan of Iran (2006-2011)

Nasim Valizadeh
Department of Hematology and Medical Oncology, Urmia University of Medical Science, Urmia,Iran
,
Rahim Mehdioghli
Department of Internal Medicine, Urmia University of Medical Science, Urmia, Iran
,
Ramin Behroozian
Department of Gastroenterology, Urmia University of Medical Science, Urmia, Iran
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Epidemiologic and etiologic studies help in the prevention of disease and improve surveillance of affected patients. The aim of this study was to study the etiology and epidemiology of HCC in West Azarbaijan of Iran. Materials and Methods: In this cross-sectional, retrospective study, medical records of 60 patients with HCC who were diagnosed between 2006 and 2011 in West Azarbaijan of Iran were analyzed for age, sex, location, presence of liver cirrhosis and/or well-known risk factors of HCC. Data were analyzed by SPSS 17 software. Results: From 60 patients with HCC, 75% were male and 25% were female. Mean age of the patients was 63.47 years. 51.66% were from rural areas and 48.33% were from urban areas. 43.33% of HCC patients were cirrhotic while 56.66% patients were non-cirrhotic. Of the 26 cirrhotic patients, 57.69% were seropositive for hepatitis B surface antigen (HBsAg), 15.38% not only had history of excess alcohol intake but were also HBsAg positive, 3.84% had history of alcoholism, 3.84% had history of Wilson disease and the rest (19.24%) had cryptogenic cirrhosis. Of the 34 non-cirrhotic patients, 35.29% were positive for HBsAg. None of the 60 patients with HCC had positive serology for hepatitis C virus (HCV) or history of hepatitis C infection. Conclusion: In our study, most of the patients (>50%) with HCC did not have underlying liver cirrhosis. In the cirrhotic patients, hepatitis B infection was the most common predisposing factor, followed by hepatitis B infection concomitant with alcoholism, alcoholism alone and Wilson disease. In the remaining cirrhotic patients, we could not find any predisposing factor for cirrhosis. Infection with HCV was not found in our studied group. We concluded that etiology of HCC in our province is different from that in the western countries.

Keywords

Etiology - epidemiology - hepatocellular carcinoma - risk factor


Publication History

Article published online:
20 July 2021

© 2012. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Jemal A, Bray F, Center MM, Ferlay J , Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69.
  • 2 Epidemiology and etiologic association of associations of hepatocellular carcinoma. Up to date.011; 19.2 version.
  • 3 Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. Contribution of Hepatitis B virus and Hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529.
  • 4 Munoz N, Bosch, X. Epidemiology of hepatocellular carcinoma. In: Neoplasms of the Liver, In: Okuda, K, Ishak, KG, Editors, Tokyo: Springer; 1989. p.3.
  • 5 McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr. International trends and patterns of primary liver cancer. Int J Cancer 2001;94:290-6.
  • 6 Yu MW, Chen CJ. Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 1993;53:790-4.
  • 7 Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: A nested case-control study among men. J Natl Cancer Inst 2001;93:1644-51
  • 8 Kumar V, Fausto N, Abbas A. Robbins and Cotran Pathologic Basis of Disease (7 th ed).Philadelphia, Saunders 2003. p.914- 7
  • 9 Trevisani F, D′Intino PE, Caraceni P, Pizzo M, Stefanini GF, Mazziotti A, et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Cancer (Phila.) 1995;75:2220-32.
  • 10 Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinical-histopathological study of 804 North American patients. Am J Clin Pathol 1996;105:65-75.
  • 11 Brechot C, Jaffredo F, Lagorce D, Gerken G, Meyer zum Büschenfelde K, Papakonstontinou A, et al. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: Results of a European concerted action. J Hepatol 1998;29:173-83.
  • 12 Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M, et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998;29:944-52.
  • 13 Idilman R, De Maria N, Colantoni A, Van Thiel DH. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J Viral Hep 1998;5:285-99.
  • 14 Goetze T, Schuette K, Bornschein J, Kipper M, Mohnike K, Malfertheiner P, et al. Epidemiology and clinical characterization of HCC in a tertiary center in eastern Germany. J Clin Oncol 29:2011 (suppl; abstr e12010)
  • 15 Chiesa R, Donato F, Tagger A, Favret M, Ribero ML, Nardi G, et al. Etiology of Hepatocellular Carcinoma in Italian Patients with and without Cirrhosis. Cancer Epidemiol Biomarkers Prev 2000;9:213-6.
  • 16 Iqbal S, Iman N, Khan H, Rahman S, Hameed A, Wadud Khan A, et al. Predisposing Factors for Hepatocellular Carcinoma in North Of Pakistan. J Med Sci 2010;18:63-6.
  • 17 Uzunalimoðlu O, Yurdaydin C, Çetinkaya H, Bozkaya H, Sahin T, Colakoðlu S, et al . Risk Factors for Hepatocellular Carcinoma in Turkey. Dig Dis Sci 2001;46:1022-8.
  • 18 Franceschi S, Raza SA. Epidemiology and prevention of hepatocellular carcinoma. Cancer Lett 2009;286:5-8